Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

BACKGROUND: To evaluate the antitumour activity and safety of metronomic cyclophosphamide vs megestrol acetate in progressive and advanced cancer patients having exhausted all effective therapies under standard care. METHODS: Patients were randomly assigned to receive orally metronomic cyclophospham...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Penel, N, Clisant, S, Dansin, E, Desauw, C, Dégardin, M, Mortier, L, Vanhuyse, M, Bonodeau, F, Fournier, C, Cazin, J-L, Adenis, A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2010
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856003/
https://ncbi.nlm.nih.gov/pubmed/20354522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605623
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak